<?xml version="1.0" encoding="UTF-8" standalone="yes"?><Drug id="3536" name="pemetrexed disodium"><HDS>Launched</HDS><RegulatoryDesignations><RegulatoryDesignation id="5">Accelerated Approval</RegulatoryDesignation><RegulatoryDesignation id="1">Orphan Drug</RegulatoryDesignation></RegulatoryDesignations><Actions><Action id="372" type="primary">Thymidylate synthase inhibitor</Action><Action id="135" type="primary">DHFR inhibitor</Action><Action id="374" type="primary">Transferase inhibitor</Action><Action id="181" type="primary">GAR transformylase inhibitor</Action><Action id="1545" type="secondary">Anticancer</Action><Action id="1569" type="secondary">Anticancer antimetabolite</Action><Action id="805" type="secondary">Folate modulator</Action></Actions><Indications><Indication id="1240" type="primary">Mesothelioma</Indication><Indication id="3466" type="primary">Metastatic bladder cancer</Indication><Indication id="3665" type="primary">Metastatic non small cell lung cancer</Indication><Indication id="3736" type="primary">Chordoma</Indication><Indication id="1261" type="secondary">Small-cell lung cancer</Indication><Indication id="127" type="secondary">Stomach tumor</Indication><Indication id="1516" type="secondary">Biliary cancer</Indication><Indication id="1728" type="secondary">Acute lymphoblastic leukemia</Indication><Indication id="1731" type="secondary">Acute myelogenous leukemia</Indication><Indication id="1768" type="secondary">Nasopharyngeal carcinoma</Indication><Indication id="1772" type="secondary">Osteosarcoma</Indication><Indication id="249" type="secondary">Pancreas tumor</Indication><Indication id="3146" type="secondary">Gallbladder tumor</Indication><Indication id="3246" type="secondary">Hormone refractory prostate cancer</Indication><Indication id="3666" type="secondary">Metastatic stomach cancer</Indication><Indication id="49" type="secondary">Breast tumor</Indication><Indication id="623" type="secondary">Head and neck tumor</Indication><Indication id="725" type="secondary">Solid tumor</Indication><Indication id="755" type="secondary">Lung tumor</Indication><Indication id="799" type="secondary">Ovary tumor</Indication><Indication id="989" type="secondary">Colorectal tumor</Indication></Indications><Entities><Entity>Chemical</Entity></Entities><OriginatorCompany id="17810">Eli Lilly &amp; Co</OriginatorCompany></Drug>